Diagnosis of Latent Tuberculosis Infection in Personnel of Various Institutions and Determination of the Risk Group for Tuberculosis

Early diagnosis of tuberculosis remains essential for the prevention of the disease and control of its incidence. The diagnosis of latent tuberculosis infection (LTBI) has significantly improved over the last years due to the use of new immunological tests, including the Diaskintest.

The aim of the study was to assess the potential of immunological assays for diagnosis of latent tuberculosis infection and determination of risk groups for tuberculosis among personnel of different institutions.

Materials and methods: in 2015–2018, a prospective group-control study was conducted that included employees of various medical centres (n = 154) and healthy individuals (n = 30). There were no significant age differences between the subjects. All the subjects included in the study shared their medical history, underwent general examination, X-ray examination, and were tested with Diaskintest. Multispiral computed tomography (MSCT) of the chest was performed for every subject with a positive Diaskintest result.

Results: the comparison of the number of persons with LTBI in general care hospitals, personnel of a manufacturing firm, and among healthy individuals showed that the risk of being infected with Mycobacterium tuberculosis is very similar in all the groups (from 6.8 to 10.0 %). The highest risk of developing LTBI was found in people who worked in an infectious area for more than 5 years (48.4 %). The analysis of the level of immune complexes (ICs) demonstrated that individuals with LTBI did not have isotypes of IgG3 and IgE immune complexes, which are found in patients with tuberculosis. The identification of particular isotypes indicates a borderline state between LTBI and tuberculosis and requires therapeutic intervention.

Conclusions: the use of the Diaskintest makes it possible to distinguish groups of employees of various institutions who are at a higher risk of developing tuberculosis. At the same time, determination of the ICs helps to reveal the borderline condition which requires medical intervention.

1. Bothamley G. The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis. Breathe (Sheff). 2017;13(3):e65–e71. https://doi.org/10.1183/20734735.005517

2. Dhega K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z, et al. Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med. 2014;2(4):321–38. https://doi.org/10.1016/S2213-2600(14)70031-1

3. Nechaeva OB. TB situation in Russia. Tuberkulez i bolezni legkih = Tuberculosis and Lung Diseases. 2018;96(8):15–24 (In Russ.) https://doi.org/10.21292/2075-1230-2018-96-8-15-24

4. Zellweger J-P. Current options for the management of multidrug-resistant tuberculosis (review). Meditsinskii al’yans = Medical Alliance. 2017;1:22–8 (In Russ.)

5. Zinchenko YuS, Basancova NYu, Starshinova AYa, Umutbaeva GB, Churilov LP. Tuberculosis today: the main trends of research on prevention, diagnosis and treatment. Rossiiskie biomeditsinskie issledovaniya = Russian Biomedical Research. 2018;3(4):24–34 (In Russ.)

6. Starshinova AA, Pavlova MV, Dovgalyuk IF, Ovchinnikova YuE, Yalfimov AN. Influence of risk factors on the development and course of tuberculosis infection in children from family contact in the present-day socioepidemiological situation. Tuberkulez i bolezni legkih = Tuberculosis and Lung Diseases. 2010;87(6):34–9 (In Russ.)

7. Aksenova VA, Baryshnikova LA, Klevno NI, Sokol’skaya EA, Dolzhenko EN, Shuster А, et al. New screening and diagnostic options of various traits of TB infection among children and adolescents in Russia. Voprosy sovremennoj pediatrii = Current Pediatrics. 2011;10(4):16–22 (In Russ.)

8. Vasil’eva EA, Verbov NV, Totolyan AA. Immunological methods in the differential diagnosis of active pulmonary tuberculosis and latent tuberculosis infection. Meditsinskii al’yans = Medical Alliance. 2015;1:92–3 (In Russ.)

9. Slogotskaya LV. Immunological skin test in tuberculosis — history and the present. Tuberkulez i bolezni legkih = Tuberculosis and Lung Diseases. 2013;5:39–46 (In Russ.)

10. Moiseeva NN, Odinec VS. Analysis of the results of the use of the recombinant «Diaskintest» tuberculosis allergen for mass diagnostics. Meditsinskii al’yans = Medical Alliance. 2015;1:132–3 (In Russ.)

11. Slogotskaya LV, Litvinov V, Ovsyankina E, Seltsovsky P, Kudlay DA. Results of QuantiFeron-TB Gold in tube and skin testing with recombinant proteins CFP-10-ESAT-6 in children and adolescents with TB or latent TB. Paediatric Respiratory Reviews. 2013;14(2):S65.

12. Slogotskaya LV, Bogorodskaya Е, Ivanova D, Makarova M, Guntupova L, et al. Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non-tuberculosis diseases. European Respiratory Journal. 2013;42(S57):1995.

13. Slogotskaya LV, Bogorodskaya E, Sentchichina O, Ivanova D, Nikitina G, et al. Effectiveness of tuberculosis detection using a skin test with allergen recombinant (CFP-10-ESAT-6) in children. European Respiratory Journal. 2015;46(S59):РА4524.

14. Shovkun L, Aksenova V, Kudlay D, Sarichev A. The role of immunological tests in the diagnosis of tuberculosis infection in children with juvenile idiopathic arthritis (JIA). European Respiratory Journal. 2018;52(S62):A2733.

15. Aksyonova VA, Baryshnikova LA, Dolzhenko EN, Kudlay DA. Tuberculosis screening in children today: important issues. Doktor.Ru = Doctor.Ru. 2012;8(76):27–9 (In Russ.)

16. Slogotskaya LI, Litvinov VI, Seltsovsky PP, Shuster AM, Martyanov VA, Кudlay DА, et al. A skin test with recombinant allergen of Mycobacterium tuberculosis (Diaskintest ® ) to detect tuberculosis in HIV patients. Pul’monologiya = Russian Pulmonology. 2011;1:60–4 (In Russ.) https://doi.org/10.18093/0869-0189-2011-0-1-60-64

17. Starshinova AA, Istomina EV, Zinchenko YuS, Filatov MV, Landa SB, Burdakov VS, et al. Diagnostic value of specific immune complexes in detection of active tuberculosis infection. Meditsinskaya immunologiya = Medical Immunology (Russia). 2019;21(2):269–78 (In Russ.) https://doi.org/10.15789/1563-0625-2019-2-269-278

18. Yablonskiy PK. Ftiziatriya. Phthisiology. National clinical guidelines. Moscow: GEOTAR-Media; 2016 (In Russ.)

19. Filatov MV, Landa SB. Methods for determining the characteristics of the isotypic composition of immune complexes and their use in therapy and diagnosis. Patent of the Russian Federation No. 2634861; 2018 (In Russ.)

20. Landa SB, Filatov MV, Arutyunyan AV, Varfolomeeva YeV. Study of plasma megamolecular complexation by laser correlation spectroscopy. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics. 2008;4:37–41 (In Russ.)

21. Korablev PV, Landa SB, Semenova EV, Filatov MV. Dynamic light scattering — a simple and sensitive method of determination immune complexes in biological liquids. BIOpreparaty. Profilaktika, diagnostika, lechenie = BIOpreperations. Prevention, Diagnosis, Treatment. 2015;(2):53–8 (In Russ.)

22. Mamaev AN, Kudlay DA. Data visualization in presentations, reports and studies. Moscow: Prakticheskaya medicina; 2011 (In Russ.)